{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:08:28Z","timestamp":1787620108039,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ijantimicag.2018.05.010","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T05:28:24Z","timestamp":1527139704000},"page":"127-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy"],"prefix":"10.1016","volume":"52","author":[{"given":"Francesco","family":"Menichetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tascini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Busani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Viaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Maria","family":"Rossolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7265-3698","authenticated-orcid":false,"given":"Fabio","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Iannazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0001","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00134-017-4878-x","article-title":"Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach","volume":"43","author":"Bassetti","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0002","unstructured":"Tackling Drug-Resistant Infections Globally: final report and recommendations. The review on antimicrobial resistance; chaired by Jim O'Neill, 2016. Available at:\nhttps:\/\/amr-review.org\/sites\/default\/files\/160518_Final%20paper_with%20cover.pdf, [last accessed May 2018]"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0003","series-title":"Surveillance of antimicrobial resistance in Europe 2016","article-title":"Antimicrobial resistance surveillance in Europe 2016","year":"2016"},{"key":"10.1016\/j.ijantimicag.2018.05.010_sbref0003","series-title":"Rapporti ISTISAN 10\/37, 2010, Rome","article-title":"AR-ISS: sorveglianza dell'antibiotico-resistenza in Italia","author":"Alfonsi","year":"2010"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0005","unstructured":"European Centre for Disease Prevention and Control, ECDC country visit to Italy to discuss antimicrobial resistance issue, 2017. Available at: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/AMR-country-visit-Italy.pdf, [last accessed May 2018]."},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0006","unstructured":"Piano Nazionale di contrasto dell'antimicrobico-resistenza 2017-2020. Available at: http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2660_allegato.pdf, [last accessed May 2018]."},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nm.4465","article-title":"The role of vaccines in preventing bacterial antimicrobial resistance","volume":"24","author":"Jansen","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0008","article-title":"How can vaccines contribute to solving the antimicrobial resistance problem?","volume":"3","author":"Lipsitcha","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0009","unstructured":"Istituto Superiore di Sanit\u00e0, Dati di sorveglianza delle malattie batteriche invasive aggiornati al 3 aprile 2017, Rome. Available at: http:\/\/www.iss.it\/binary\/mabi\/cont\/Report_MBI_20170403_finale.pdf [last accessed May 2018]."},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0010","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage","volume":"297","author":"Singleton","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0011","first-page":"601","article-title":"Inappropriate antibiotic prescribing in managed care subjects with influenza","volume":"17","author":"Misurski","year":"2011","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0012","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/ACO.0000000000000097","article-title":"Important issue for perioperative systemic antimicrobial prophylaxis in surgery","volume":"27","author":"Sinha","year":"2014","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0013","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0014","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMcp1314291","article-title":"Clinical practice. Care of the asplenic patient","volume":"371","author":"Rubin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0015","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC, 2010","volume":"59","year":"2010","journal-title":"MMWR"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0016","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0017","series-title":"Point prevalence survey of healthcare- associated infections and antimicrobial use in European acute care hospitals","year":"2013"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2018.05.010_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12427","article-title":"ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients","volume":"20","author":"Tacconelli","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0019","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/CMR.00002-11","article-title":"Food animals and antimicrobials: impacts on human health","volume":"24","author":"Marshall","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0020","unstructured":"European Medicines Agency. ESVAC strategy 2016-2020 including benefits of the collection of dataon sales and use per species, Europe, 2017. Available at: https:\/\/ec.europa.eu\/health\/amr\/sites\/amr\/files\/ev_20170426_pres_03.pdf [last accessed May 2018]."},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0021","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12917-017-1131-3","article-title":"Antimicrobial drug use in food-producing animals and associated human health risks: what, and how strong, is the evidence?","volume":"13","author":"Hoelzer","year":"2017","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0022","doi-asserted-by":"crossref","first-page":"208","DOI":"10.21037\/atm.2017.04.04","article-title":"Biomarker-guided antibiotic therapy \u2013 strengths and limitations","volume":"5","author":"Nora","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0023","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2010.07.012","article-title":"Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis","volume":"26","author":"Georgopoulou","year":"2011","journal-title":"J Crit Care"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0025","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial","volume":"16","author":"de Jong","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0026","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/cclm-2015-0243","article-title":"Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin","volume":"54","author":"Enguix-Armada","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0027","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0028","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1128\/CMR.00066-16","article-title":"Antimicrobial stewardship: how the microbiology laboratory can right the ship","volume":"30","author":"Morency-Potvin","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0029","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1128\/CMR.00053-14","article-title":"Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis","volume":"29","author":"Buehler","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0030","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/cid\/cit498","article-title":"Impact of rapid organism identification via matrix-assisted laser desorption\/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia","volume":"57","author":"Huang","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0031","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/INF.0000000000000844","article-title":"Antibiotic susceptibility testing: present and future","volume":"34","author":"Arena","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0032","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/cid\/civ447","article-title":"Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing","volume":"61","author":"Banerjee","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0033","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11908-017-0575-8","article-title":"De-escalating antibiotic use in the inpatient setting: strategies, controversies, and challenges","volume":"19","author":"Daniel Markley","year":"2017","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171218","article-title":"Benefits and unintended consequences of antimicrobial de-escalation: implications for stewardship programs","volume":"12","author":"Hughes","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0035","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1007\/s10096-012-1662-2","article-title":"Utility and safety of procalcitonin in an antimicrobial stewardship program (ASP) in patients with malignancies","volume":"31","author":"Liew","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0036","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s10156-003-0279-X","article-title":"Optimizing outcomes with antimicrobial therapy through pharmacodynamic profiling","volume":"9","author":"Nicolau","year":"2003","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0037","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ijantimicag.2017.11.013","article-title":"Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of \u03b2-lactams administered by continuous infusion: a prospective observational study","volume":"51","author":"Carrie","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0038","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/cid\/cit582","article-title":"Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia","volume":"57","author":"Falcone","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0039","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2165\/10895960-000000000-00000","article-title":"Pharmacokinetic and pharmacodynamic parameters of antimicrobials: potential for providing dosing regimens that are less vulnerable to resistance","volume":"48","author":"Adembri","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0040","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1586\/17512433.2016.1172209","article-title":"Therapeutic drug monitoring of anti-infective agents in critically ill patients","volume":"9","author":"Jager","year":"2016","journal-title":"Exp Rev Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0041","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1093\/jac\/dkw408","article-title":"Therapeutic drug monitoring in the past 40 years of the Journal of Antimicrobial Chemotherapy","volume":"71","author":"Reeves","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0042","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jiac.2015.02.001","article-title":"Applications of the pharmacokinetic\/pharmacodynamic (PK\/PD) analysis of antimicrobial agents","volume":"21","author":"As\u00edn-Prieto","year":"2015","journal-title":"J Infect Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2018.05.010_bib0043","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.ajic.2006.05.227","article-title":"Pharmacodynamics: relation to antimicrobial resistance","volume":"34","author":"Rybak","year":"2006","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0044","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.diagmicrobio.2008.02.012","article-title":"Antimicrobial stewardship: concepts and strategies in the 21st century","volume":"61","author":"Owens","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/j.1875-9114.2012.01154.x","article-title":"Antimicrobial stewardship: a matter of process or outcome?","volume":"32","author":"Khadem","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0046","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1086\/678057","article-title":"Antimicrobial stewardship programs in inpatient hospital settings: a systematic review","volume":"35","author":"Wagner","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0047","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00134-017-5036-1","article-title":"Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM\/ESCMID\/WAAAR round table on multi-drug resistance","volume":"44","author":"De Waele JJ","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0048","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/cid\/ciw780","article-title":"What is the more effective antibiotic stewardship intervention: pre prescription authorization or post prescription review with feedback?","volume":"64","author":"Tamma","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0049","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/cid\/cir025","article-title":"Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention","volume":"52","author":"Schwaber","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.05.010_bib0050","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/cid\/ciw323","article-title":"Antibiotic stewardship programs in U.S. acute care hospitals: findings from the 2014 National Healthcare Safety Network Annual Hospital Survey","volume":"63","author":"Pollack","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918301419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918301419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:31:49Z","timestamp":1760376709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918301419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0924857918301419"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.05.010","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}